magnifying glass
logo for Rubius Therapeutics

Rubius Therapeutics

Get Full Access

Description

Founded in 2013, Rubius Therapeutics is headquartered in Cambridge, Massachusetts. They are a biopharmaceutical company that creates red blood cells and transfo... Read More

Headquarters

Headquarters:

399 Binney St, Ste 300, Cambridge, Massachusetts, 02139, United States
Phone

Phone:

(617) 679-9600
Employees

Employees:

223
Revenue

Revenue:

$75 Million
Stock Symbol

Stock Symbol:

RUBY
Rubius Therapeutics's Social Media
SIC Code 28,283
NAICS Code 32541,325
Ticker NASDAQ: RUBY
Popular Searches:

Rubius Therapeutics Inc

Rubius Therapeutics, Inc.

Rubius Therapeutics

Rubius Therapeutics , Inc.

Rubius Therapeutics Inc.

Top Competitors of Rubius Therapeutics

Employess
101
revenue
$18 Million

1

Employess
62
revenue
$12 Million

2

Employess
70
revenue
<$5 Million

3

Employess
80
revenue
$8 Million

4

Employess
53
revenue
<$5 Million

5

Employess
59
revenue
$12 Million

6

Rubius Therapeutics's Org Chart

Pablo Cagnoni
Pablo Cagnoni

Chief Executive Officer

PhonePhoneEmailEmail
Dannielle Appelhans
Dannielle Appelhans

Chief Operating Officer

PhonePhoneEmailEmail
Jose Carmona
Jose Carmona

Chief Financial Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

Rubius Therapeutics Company Metrics

Company Insights
Employee Growth Rate
Revenue
QuarterRevenue

'20 - Q3

47935000

'20 - Q4

75278000

'21 - Q1

75278000

'21 - Q2

75278000

Rubius Therapeutics's Tech Stack

Microsoft Project

By

Microsoft

Office 365

By

Microsoft

ADP

By

ADP

WordPress.org

By

Automattic

Drupal

By

Drupal

Gravity Forms

By

Rocketgenius
See more technologies

Rubius Therapeutics News & Media

Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial of RTX-224, a Broad Immune Agonist, for the Treatment of Certain Solid Tumors

CAMBRIDGE, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune disease, today announced that the first patient has been dosed in its Phase 1/2 clinical trial of RTX-224 for the treatment of patients with certain relapsed/refractory or locally advance

Rubius Therapeutics Recaps 2021 Achievements and Outlines 2022 Objectives Across the RED PLATFORM at the 40th Annual J.P. Morgan Healthcare Conference

Continuing Dose Escalation in Single-Agent Phase 1 RTX-240 Clinical Trial in Advanced Solid Tumors with No Dose-Limiting Toxicities Observed to Date and an NK Cell Dose Response with Clinical Results Expected in Q1’22

Rubius Therapeutics to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™ for the treatment of cancer and autoimmune diseases, today announced Pablo J. Cagnoni, M.D., president and chief executive officer, will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12
Subscribe to "Rubius Therapeutics" News

Frequently Asked Questions regarding Rubius Therapeutics

Where are Rubius Therapeutics’s headquarters?

Rubius Therapeutics’s headquarters are in 399 Binney St, Ste 300, Cambridge, Massachusetts, 02139, United States

What is Rubius Therapeutics’s phone number?

Rubius Therapeutics’s phone number is (617) 679-9600

What is Rubius Therapeutics’s stock symbol?

Rubius Therapeutics’s stock symbol is RUBY

What is Rubius Therapeutics’s official website?

Rubius Therapeutics’s official website is //www.rubiustx.com

What is Rubius Therapeutics’s Revenue?

Rubius Therapeutics’s revenue is $75 Million

What is Rubius Therapeutics’s SIC code?

Rubius Therapeutics’s SIC: 28,283

What is Rubius Therapeutics’s NAICS code?

Rubius Therapeutics’s NAICS: 32541,325

How many employees are working in Rubius Therapeutics?

Rubius Therapeutics has 223 employees

What is Rubius Therapeutics’s industry?

Rubius Therapeutics is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare

Who are Rubius Therapeutics’s main competitors?

Rubius Therapeutics's main competitors are: Celularity, Semma Therapeutics, Gamida Cell, miRagen Therapeutics

What is Rubius Therapeutics's tech stack?

The technologies that are used by Rubius Therapeutics are: Microsoft Project, Office 365, ADP, WordPress.org

Who is Rubius Therapeutics's CEO?

Rubius Therapeutics's CEO is Pablo Cagnoni

Who is Rubius Therapeutics's CFO?

Rubius Therapeutics's CFO is Jose Carmona

See more information about Rubius Therapeutics

Browse ZoomInfo’s Directories